2-96254998-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_017849.4(TMEM127):c.245-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_017849.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM127 | NM_017849.4 | c.245-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 3 | ENST00000258439.8 | NP_060319.1 | ||
TMEM127 | NM_001193304.3 | c.245-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 3 | NP_001180233.1 | |||
TMEM127 | NM_001407282.1 | c.-8-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 2 | NP_001394211.1 | |||
TMEM127 | NM_001407283.1 | c.-8-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 2 | NP_001394212.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM127 | ENST00000258439.8 | c.245-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 3 | 1 | NM_017849.4 | ENSP00000258439.3 | |||
TMEM127 | ENST00000432959.1 | c.245-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 3 | 1 | ENSP00000416660.1 | ||||
TMEM127 | ENST00000435268.1 | c.-8-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 2 | 3 | ENSP00000411810.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.245-1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide upstream from coding exon 2 of the TMEM127 gene. RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). Another alteration impacting the same acceptor site (c.245-1G>C) has been observed in multiple individuals with a personal and/or family history that is consistent with TMEM127-related disease (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Hereditary pheochromocytoma-paraganglioma Pathogenic:1
This sequence change affects an acceptor splice site in intron 2 of the TMEM127 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with TMEM127-related conditions (PMID: 20154675). ClinVar contains an entry for this variant (Variation ID: 1791501). Studies have shown that disruption of this splice site results in activation of a cryptic splice site, and produces a non-functional protein and/or introduces a premature termination codon (internal data). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.